Roles of probiotics against HPV through the gut-vaginal axis
- PMID: 39520180
- DOI: 10.1002/ijgo.16005
Roles of probiotics against HPV through the gut-vaginal axis
Abstract
Human papillomavirus (HPV) is a sexually transmitted virus, whose persistent infection is the main reason for invasive cervical cancer (ICC), which is the fourth most common type of cancer in women, with more than 500 000 new cases every year. After infection, various alterations occur in the host, facilitating the virus's evasion of immune system clearance and promoting its proliferation. Oral probiotic consumption can influence the whole body's immunity, inflammatory reflection, neural, endocrine humoral, metabolic pathways and other organs by adjusting the components of gut microbiota (GM). Some evidence shows there is a tight connection between GM and vaginal microbiota (VM), which is referred to as the gut-vaginal axis. This review investigates the potential role of probiotics in clearing HPV via the gut-vagina axis, emphasizing the effectiveness of Lactobacillus in preventing vaginal diseases and suggesting its potential for HPV clearance. Understanding the role of probiotics in the gut-vagina axis could pave the way for new strategies to reduce and eliminate HPV and related diseases.
Keywords: HPV clearance; gut‐vaginal axis; oral administration; potential treatment; probiotics.
© 2024 International Federation of Gynecology and Obstetrics.
References
REFERENCES
-
- National Cancer Institute. HPV and Cancer. 2019 Accessed June 1, 2023. https://www.cancer.gov/about‐cancer/causes‐prevention/risk/infectious‐ag...
-
- Nicolò S, Tanturli M, Mattiuz G, et al. Vaginal lactobacilli and vaginal Dysbiosis‐associated bacteria differently affect cervical epithelial and immune homeostasis and anti‐viral defenses. Int J Mol Sci. 2021;22:6487.
-
- World Health Organization. Donors making a difference: Funding a range of lifesaving immunization for people of all ages. 2022 Accessed June 1, 2023. https://www.who.int/news‐room/feature‐stories/detail/donors‐making‐a‐dif...
-
- Frega A, Sopracordevole F, Scirpa P, et al. The re‐infection rate of high‐risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment. Med Sci Monit. 2011;17:CR532‐CR535.
-
- Łaniewski P, Cui H, Roe DJ, et al. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci Rep. 2019;9:7333.